Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
30 May 2025 | Story Prof Mikateko Mathebula | Photo Supplied
Africa Month Alliance
Pictured (from left to right): Prof Faith Mkwananzi, Dr Kapambwe Mwelwa, Prof Lochner Marais, Prof Chikumbutso Manthalu, and Prof Mikateko Mathebula.

Through collaborative agreements with the University of Malawi and the University of Zambia, the University of the Free State (UFS) has established the Research Alliance for Higher Education in Africa (RAHEdA), a dynamic initiative aimed at enhancing research capacity and partnerships within Sub-Saharan Africa.

The initiative forms part of the UFS’s SARChI Chair in Higher Education and Human Development (HEHD) research programme. 

The collaborative agreements align with the UFS’s Vision 130 strategy in relation to internationalisation, emphasising the important role that intra-African mobility visits play in establishing relationships with universities on the continent. It also fosters knowledge exchange and engagement and allows for careful planning and strategy meetings. 

In 2024, the HEHD hosted Dr Kapambwe Mwelwa, a lecturer in the University of Zambia’s Department of Educational Administration and Policy Studies, and Prof Chikumbutso Manthalu, Head of Higher Education and Professional Development in the University of Malawi’s School of Education, for such a visit. Their engagements included research seminars, a PhD presentation day, and collaborative strategy sessions with UFS academics, including Prof Faith Mkwananzi and Prof Mikateko Mathebula from the UFS’s Centre for Development Support (CDS), who are co-founders of RAHEdA.

“During these discussions, an ambitious but feasible roadmap was laid out for the next three to five years,” Prof Mkwananzi said. “These activities include online workshops for staff and postgraduate students at all partner institutions, and a new webinar series that focuses on profiling, advancing, and celebrating thought leaders, higher education scholars, and scholarship in Africa.” 

The inaugural webinar was held on 21 May 2025. Speaker Prof Siseko Kumalo, Associate Professor at the University of Johannesburg’s Ali Mazrui Centre for Higher Education Studies, spoke on ‘Orality as the Bulwark of the Humanities?’, set the bar high for the webinar series through his compelling and original response to this timely question, as scholars around the world contemplate appropriate responses to the rise and influence of artificial intelligence in higher education teaching, learning, and assessment.

Funding to support RAHEdA has been generously provided by Prof Melanie Walker, Distinguished Professor and SARChI Chair in Higher Education and Human Development.

• For information on how to get involved and for updates on RAHEdA, please contact Prof Mikateko Mathebula at MathebulaM@ufs.ac.za

News Archive

Nano research at the UFS opens door to smart drugs
2011-06-27

 

Prof. Lodewyk Kock, outstanding professor in our Department of Microbial, Biochemical and Food Biotechnology

Novel antifungal, anticancer and anti-malaria drugs that have been identified in the research of Prof. Lodewyk Kock, outstanding professor in the Department of Microbial, Biochemical and Food Biotechnology at our university, will be disclosed later this year at major international conferences in Asia, Europe and the USA. Prof. Kock will be the keynote speaker at these conferences. 

His presentations will be based on the department’s discovery of yeast assays linked to a new nanotechnology for medicine. The assays were recently discovered by his group and can be applied in the development of novel antifungal, anticancer and anti-malaria drugs.
 
Prof. Kock’s focused research at the university, which now also includes his novel nanotechnology for Biology, began in 1982 in collaboration with Prof. Pieter van Wyk (Centre for Microscopy). He recently collaborated with Prof. Hendrik Swart (Department of Physics).
 
Prof. Kock says the development of novel anti-malaria drugs in particular is getting attention across the world due to the high rates of morbidity and mortality caused by the disease worldwide. Approximately 225 million people are infected annually and about a million (many in Africa) die each year. “Many potential smart drugs have been identified with this research and should now be tested further,” says Kock.
  
These new drugs will be disclosed during Prof. Kock’s keynote addresses at the International Conference and Exhibition on Pharmaceutical Regulatory Affairs in Baltimore, USA, from 6 to 7 September 2011, the Medichem 2011 in Beijing, China from 9 to 11 August 2011 and the XVI Congress of European Mycologists in Greece, from 19 to 23 September 2011.

 

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept